CAS: 748146-89-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | WAY-383487 REF: IN-DA023ODECAS: 748146-89-6 | 95% | 159,00 €~609,00 € | Mié 07 May 25 |
 | CDK9-IN-30 REF: 54-BUP07642CAS: 748146-89-6 | ≥98% | 481,00 €~1.866,00 € | Jue 08 May 25 |
 | CDK9-IN-30 REF: TM-T9632CAS: 748146-89-6 | 99.76% | 56,00 €~1.378,00 € | Mié 14 May 25 |
Ref: IN-DA023ODE
| 10mg | 159,00 € | ||
| 25mg | 227,00 € | ||
| 50mg | 509,00 € |
Entrega estimada en Estados Unidos, el Miércoles 7 de Mayo de 2025
Ref: 54-BUP07642
| 25mg | 481,00 € | ||
| 50mg | 705,00 € | ||
| 100mg | 966,00 € | ||
| 500mg | 1.866,00 € |
Entrega estimada en Estados Unidos, el Jueves 8 de Mayo de 2025
CDK9-IN-30
CAS:748146-89-6
CDK9-IN-30 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
Fórmula:
C16H20FNO3
Pureza:
99.76%
Forma y color:
Solid
Peso molecular:
293.33
Ref: TM-T9632
| 1mg | 56,00 € | ||
| 5mg | 119,00 € | ||
| 10mg | 187,00 € | ||
| 25mg | 316,00 € | ||
| 50mg | 472,00 € | ||
| 100mg | 658,00 € | ||
| 500mg | 1.378,00 € | ||
| 1mL*10mM (DMSO) | 114,00 € |
Entrega estimada en Estados Unidos, el Miércoles 14 de Mayo de 2025
